neog - Neogen's E.Coli Test adopted by Japan Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan

NEOG 6.040

-0.2%

12:41 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kramer who wrote (250)	11/23/1998 8:09:00 PM
From: Mickey Szilagyi	Read Replies (1) of 441

Not much to talk about nor does it affect Neogen that much if at all. I looked up the articles in the Journal and it looks like Brewer was alleging BioPort insiders of having an edge on purchasing the Michigan Biologic Products Institute. His complaint went to the state ethics board and that is what was just dismissed. Brewer still has a suit in Ingham Circuit Court to reverse the purchase. I called Neogen and talked to IR and they are not concerned. Neogen acquired the sole rights to produce Bot Tox-B vaccine, as you said, and they think they are outside the scope of the court case. They also indicated that the Bot Tox-B vaccine is only a small part of Neogen's business. She said the Golden Nugget deal was more important. Looks like they spend $500,000 defending that case, which could have added to the bottom line. Finally a little action today. Probably due to winning their court case. FWIW, MJS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next